glp-1 medications long term side effects GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment GLP-1 Medications Infographic | Medidex

Prandial options to advance basal insulin glargine therapy: testing lixisenatide plus basal insulin versus insulin glulisine either as basal-plus or basal-bolus in type 2 diabetes: the GetGoal Duo-2 Trial

[DOI] [PubMed] [Google Scholar] 6.Solhjoo M, Goyal A, Saliba F, et al

In this review, we highlight past and recent results describing how dietary manipulation of the gut microbiota, using nutrients or specific microbes, can stimulate GLP-1 secretion in rodents and humans

The World Health Organization (WHO) requested these reviews to help shape upcoming recommendations on using these medications for obesity treatment

You typically start at a low dose of 0.8 mg and gradually increase your dosage over a period of 3090 days

Further research should explore the underlying mechanisms of these adverse events, develop mitigation strategies, and assess differences across demographic groups